@Article{,
AUTHOR = {Lydia Glick, Thenappan Chandrasekar, Scott G. Hubosky, Seth Teplitsky, Mihir Shah, Joon Yau Leong, Geoffrey Ouma, James R. Mark},
TITLE = {How I Do It: Anticoagulation management for common urologic procedures},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {27},
YEAR = {2020},
NUMBER = {6},
PAGES = {10480--10487},
URL = {http://www.techscience.com/CJU/v27n6/60353},
ISSN = {1488-5581},
ABSTRACT = {Appropriate perioperative management of antithrombotic 
medications is critical; for every patient, the risk of 
bleeding must be balanced against individual risk 
of thrombosis. There has been a rapid influx of new 
antithrombotic therapies in the past 5 years, yet 
there is a lack of clear and concise guidelines on the 
management of anticoagulant and antiplatelet therapy 
during urologic surgery. Here we describe our approach 
to perioperative antithrombotic counseling, including the timing of stopping and restarting these medications. 
These practice guidelines have been developed in 
consultation with the Vascular Medicine service at our 
institution as well as after a review of current literature, 
and apply to common urologic procedures. Many 
cases are complex and require medical consultation 
or a multidisciplinary approach to management. We 
believe that by presenting our systematic method of 
antithrombotic management, including when to involve 
other discplines, we can increase knowledge and comfort 
amongst urologists in managing these medications in 
the perioperative period.},
DOI = {}
}